This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Endocrine Diseases, Other  • Alert me on articles by topic

Richard Trubo

JAMA. 2005;294:663-667.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

San Diego—Endocrinologists have known for decades that growth hormone (GH) levels decline with age and that a deficit in this hormone can bring increases in fat mass, declines in lean mass, a greater risk of osteopenia, a decrease in exercise tolerance, and an adverse cardiac risk profile. Interest in GH and its deficiency is now on the rise—and not only for traditional medical uses of GH replacement therapy. In various settings, including the Internet, GH treatments are sometimes being touted as the latest incarnation of the "fountain of youth," miring them in controversy.

With the graying of most of the world’s developed countries, it is no surprise that the GH debate and unanswered questions about addressing the changes in levels of GH and certain other hormones in older adults are gaining unprecedented attention by researchers and clinicians.

Researchers are studying whether boosting levels of certain hormones that . . . [Full Text of this Article]

GH REPLACEMENT THERAPY?